Loading icon
Press enter or spacebar to select a desired language.
Research
Press enter or spacebar to select a desired language.

PubMed COVID-19 Clinical Care

11691 - 11700 of 57753 results found

Multifactorial Causation of Alzheimer's Disease Due to COVID-19

Date
Sunday, November 26, 2023 - 4:00 AM
Description
There are several implications of the surge in the incidence of pandemics and epidemics in the last decades. COVID-19 being the most remarkable one, showed the vulnerability of patients with neurodegenerative diseases like Alzheimer's disease (AD)

A rare cause of kidney injury: vitamin D3 intoxication

Date
Sunday, November 26, 2023 - 4:00 AM
Description
The beneficial effects of vitamin D3 treatment are known, and its side effects are documented. In connection with the case presentation, we would like to sum up the dangers of excessive vitamin D supplementation, and to draw attention to the

New Vaccine Introductions in WHO African Region between 2000 and 2022

Date
Saturday, November 25, 2023 - 4:00 AM
Description
Significant progress has been made in vaccine development worldwide. This study examined the WHO African Region's vaccine introduction trends from 2000 to 2022, excluding COVID-19 vaccines. We extracted data on vaccine introductions from the WHO

Primary and Recall Immune Responses to SARS-CoV-2 in Breakthrough Infection

Date
Saturday, November 25, 2023 - 4:00 AM
Description
Breakthrough infections in SARS-CoV-2 vaccinated individuals are an ideal circumstance for the simultaneous exploration of both the vaccine-induced memory reaction to the spike (S) protein and the primary response to the membrane (M) and nucleocapsid

Older Age, a High Titre of Neutralising Antibodies and Therapy with Conventional DMARDs Are Associated with Protection from Breakthrough Infection in Rheumatoid Arthritis Patients after the Booster Dose of Anti-SARS-CoV-2 Vaccine

Date
Saturday, November 25, 2023 - 4:00 AM
Description
Objectives: We aimed to analyse the incidence and severity of breakthrough infections (BIs) in rheumatoid arthritis (RA) patients after a COronaVIrus Disease 2019 (COVID-19) vaccination booster dose. Methods: We enrolled 194 RA patients and 1002